Targeting the renal microvasculature as a therapy for kidney disease
| Dates: | 15 April 2016 |
|---|
| Times: | 14:00 - 15:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Faculty of Life Sciences |
|---|
| Who is it for: | University staff, Current University students |
|---|
| Speaker: | Dr David Long |
|---|
|
|
The kidney contains a vast microvasculature supplying oxygen and nutrients and reclaiming reabsorbed water and solutes. Disruption to the kidney microvasculature is one of the earliest triggers in the progression of end-stage renal disease; therefore it is logical that restoring and stabilising kidney blood vessels may be an important and novel therapeutic avenue for treating renal patients. One way this can be achieved is through the administration of vascular growth factors that control blood vessel function and stability. In this lecture, I will outline recent studies from my laboratory showing the potential of vascular growth factors as a therapy for polycystic kidney disease, one of the main genetic causes of renal disease world-wide.
Sponsored by PeproTech
Speaker
Dr David Long
Organisation: University College London
Travel and Contact Information
Find event
Michael Smith Lecture Theatre
Michael Smith Building
Manchester
